L-carnitine may reduce muscle cramps in patients with cirrhosis

L-carnitine may reduce muscle cramps in patients with cirrhosis
L-carnitine appears to be safe and effective for reducing muscle cramps in patients with cirrhosis, according to a study published in the August issue of Clinical Gastroenterology and Hepatology.
(HealthDay)—L-carnitine appears to be safe and effective for reducing muscle cramps in patients with cirrhosis, according to a study published in the August issue of Clinical Gastroenterology and Hepatology.

Hiroyuki Nakanishi, from the Musashino Red Cross Hospital in Tokyo, and colleagues prospectively evaluated the ability of L-carnitine (dosed at 300 mg either three times/day [19 participants] or four times/day [23 participants] for eight weeks) to reduce in patients with cirrhosis.

The researchers found that muscle cramping was reduced in 88.1 percent of all participants at the end of the study period and disappeared for 28.6 percent of patients. Overall, the degree of muscle cramping assessed with the visual analogue scale decreased significantly from baseline (P < 0.0001). A higher dose of L-carnitine was significantly associated with a greater percentage of patients with reduced muscle cramps after eight weeks (43.5 percent in the 1,200 mg/day group versus 10.5 percent in the 900 mg/day group; P = 0.037). No adverse events were reported.

"The administration of L-carnitine may be a promising treatment for cirrhosis patients with painful muscle cramps," the authors write.


Explore further

Help for people with muscle cramps?

More information: Abstract
Full Text
Editorial

Copyright © 2015 HealthDay. All rights reserved.

Citation: L-carnitine may reduce muscle cramps in patients with cirrhosis (2015, August 3) retrieved 20 February 2019 from https://medicalxpress.com/news/2015-08-l-carnitine-muscle-cramps-patients-cirrhosis.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
8 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more